Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol)

AUTOR(ES)

Espir, Michael L. E.

RESUMO

During an eight year period, 32 patients with definite or suspected multiple sclerosis (MS) were seen with paroxysmal neurological disturbances, which included tonic seizures, paroxysmal dysarthria, paraesthesiae and pain in the limbs, as well as trigeminal neuralgia. In 21 of these patients the paroxysmal disorders were treated with carbamazepine, and in six the effect was compared with placebo. In the majority carbamazepine was effective in controlling the paroxysmal symptoms. Side-effects were troublesome in a few patients, but they could usually tolerate small doses, which still gave relief. Although the patho-physiological basis for these paroxysmal disorders remains unexplained, their response to carbamazepine suggests a common mechanism.

Documentos Relacionados

• Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine.
• Clinical trial of carbazepine (tegretol) in trigeminal neuralgia.
• Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.
• Worsening of symptoms of multiple sclerosis associated with carbamazepine
• Paroxysmal symptoms in multiple sclerosis.